| dc.contributor.author | - | |
| dc.date.accessioned | 2025-10-02T04:20:01Z | |
| dc.date.available | 2025-10-02T04:20:01Z | |
| dc.date.issued | 2021-10-19 08:25:52+00:00 | |
| dc.identifier.issn | - | |
| dc.identifier.uri | 2590-0188 | |
| dc.identifier.uri | http://digilib.fisipol.ugm.ac.id/repo/handle/15717717/34593 | |
| dc.description.abstract | - | |
| dc.format | - | |
| dc.language.iso | EN | |
| dc.publisher | Elsevier | |
| dc.relation.uri | ['https://www.elsevier.com/journals/immuno-oncology-and-technology/2590-0188/guide-for-authors', 'https://www.journals.elsevier.com/immuno-oncology-and-technology', 'https://www.elsevier.com/authors/open-access/choice#waivers'] | |
| dc.rights | ['CC BY', 'CC BY-NC-ND'] | |
| dc.subject | ['oncology', 'immunotherapy', 'Neoplasms. Tumors. Oncology. Including cancer and carcinogens', 'RC254-282'] | |
| dc.title | Immuno-Oncology and Technology | |
| dc.type | Article | |
| dc.identifier.oai | oai:doaj.org/journal:32b0bb5bf720430f8f67aa86c8aa3ab4 | |
| dc.journal.info | - | |
